Inter Parfums (IPAR) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
12 May, 2026Executive summary
Net sales for Q1 2026 rose 2% year-over-year to $345 million, with both U.S. and European operations contributing to growth despite mixed regional and brand performance.
Gross margin improved to 65.1% from 63.7%, driven by favorable brand/channel mix and efficiencies.
Net income attributable to shareholders increased 2% to $43.4 million ($1.35 per diluted share).
Strong brand execution, innovation, and new licenses supported growth, while travel retail remained robust at 7% of net sales.
Full-year 2026 guidance reaffirmed, with cautious optimism amid geopolitical disruptions and macro headwinds.
Financial highlights
Net sales: $345 million (+2%); gross profit: $224.6 million; net income: $43.4 million; diluted EPS: $1.35.
Operating income was $74 million (down 1% year-over-year), with an operating margin of 21.5%.
SG&A expenses rose to 43.6% of sales, reflecting higher royalty, logistics, and FX costs.
Cash and equivalents stood at $237 million, with working capital near $700 million and inventories reduced by 17 days year-over-year.
Dividend maintained at $3.20 per share annually, with a quarterly dividend of $0.80 per share announced.
Outlook and guidance
Full-year 2026 guidance maintained: sales of ~$1.48 billion and diluted EPS of $4.85, assuming stable FX rates.
Anticipates stronger growth in 2027, driven by new brand launches and innovation.
Management expects market growth to normalize after recent rapid expansion.
Monitoring inflationary impacts and tariff-related pressures; expects gross margin stability for 2026.
Latest events from Inter Parfums
- Voting standards for Proposal 3 and other matters clarified; majority approval required.IPAR
Proxy filing - Sustained growth, strong brand launches, and robust shareholder returns define recent performance.IPAR
Investor presentation - Key votes on directors, executive pay, and stock plan extension are set, with board support.IPAR
Proxy filing - Net sales grew 2% to $685.9M, with margin gains and strong U.S. and brand performance.IPAR
Q2 2026 - Record sales and EPS in FY2025, with strong brand growth and steady 2026 outlook.IPAR
Q4 2025 - Record Q3 sales and earnings, with 2024 guidance reaffirmed and strong holiday outlook.IPAR
Q3 2024 - Record Q2 sales and margin gains, strong new launches, and 2024 guidance reaffirmed.IPAR
Q2 2024 - Q1 2025 net sales up 5%, net income $42.5M, margins and guidance strong, key licenses renewed.IPAR
Q1 2025 - Record sales, robust innovation, and 4% growth outlook with higher dividend for 2025.IPAR
Q4 2024